Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America / Najlacnejšie knihy
Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America

Code: 09400966

Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America

by K. Rajender Reddy

There are over 180 million people with chronic HCV infection worldwide with between 2.7 and 3.9 million in the United States. Hepatitis C most significantly affects Asia and Africa, with rates up to 15% in countries such as Egypt ... more

85.63

RRP: 89.22 €

You save 3.58 €

Availability:

50/50We think title might be available. Upon your order we will do our best to get it within 6 weeks.
We search the world

Availability alert

Add to wishlist

You might also like

Give this book as a present today
  1. Order book and choose Gift Order.
  2. We will send you book gift voucher at once. You can give it out to anyone.
  3. Book will be send to donee, nothing more to care about.

Book gift voucher sampleRead more

Availability alert

Availability alert


Your agreement - Submiting you agree to the Terms and Condtions.

We will watch availability for you

Enter your e-mail address and once book will be available,
we will send you a message. It's that simple.

More about Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America

You get 215 loyalty points

Book synopsis

There are over 180 million people with chronic HCV infection worldwide with between 2.7 and 3.9 million in the United States. Hepatitis C most significantly affects Asia and Africa, with rates up to 15% in countries such as Egypt and up to 30% in certain regions such as Punjab, Pakistan. Hepatitis C places a significant burden on the public health infrastructure, as it remains the leading cause of chronic liver disease, accounting for 50-75% of primary liver cancers and is responsible for 30% of all liver transplantations. It is estimated to have cost the United States $5.5 billion in 1997, comparable to the national cost of asthma, $5.8 billion in 1994.This number is only expected to grow as the current HCV population ages, increasing overall rates of compensated cirrhosis/end-stage liver disease. The evolution of directly acting anti-virals has ushered in a new era for chronic hepatitis C. Ongoing drug development strategy has involved targeting several replication steps of the virus and the hope is to see all oral therapies by late 2014 or early 2015. Thus we are at an exciting cross roads with regard to new information and challenges with HCV: rising disease burden with associated high costs, the challenges globally and in multiple patient populations, and the impending availability of effective and well tolerated treatments. Therefore there is a need to commission an exclusive issue of GCNA for HCV.

Book details

Book category Books in English Medicine Clinical & internal medicine Hepatology

85.63

Trending among others



Collection points Bratislava a 2642 dalších

Copyright ©2008-24 najlacnejsie-knihy.sk All rights reservedPrivacyCookies


Account: Log in
Všetky knihy sveta na jednom mieste. Navyše za skvelé ceny.

Shopping cart ( Empty )

For free shipping
shop for 59,99 € and more

You are here: